Cargando…
Anticancer activity of 23,24-dihydrocucurbitacin B against the HeLa human cervical cell line is due to apoptosis and G2/M cell cycle arrest
Autores principales: | Zhang, Jun-Xiao, Hong, Wei-Tan, Hu, Chun-Yan, Wang, Wei-Qiang, Chu, Guang-Hua, Wei, Li-Hui, Chen, Liu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056111/ https://www.ncbi.nlm.nih.gov/pubmed/33884039 http://dx.doi.org/10.3892/etm.2021.10033 |
Ejemplares similares
-
23,24-Dihydrocucurbitacin B promotes lipid clearance by dual transcriptional regulation of LDLR and PCSK9
por: Li, Hui-hui, et al.
Publicado: (2019) -
The Inhibition of Gastric Cancer Cells’ Progression by 23,24-Dihydrocucurbitacin E through Disruption of the Ras/Raf/ERK/MMP9 Signaling Pathway
por: Liu, Huiping, et al.
Publicado: (2022) -
Identification of 16,25-O-diacetyl-cucurbitane F and 25-O-acetyl-23,24-dihydrocucurbitacin F as novel anti-cancer chemicals
por: Wang, Wenxue, et al.
Publicado: (2018) -
Unraveling and engineering the production of 23,24-bisnorcholenic steroids in sterol metabolism
por: Xu, Li-Qin, et al.
Publicado: (2016) -
Retraction Note: Gold Nanoparticles-enabled Efficient Dual Delivery of Anticancer Therapeutics to HeLa cells
por: Farooq, Muhammad U., et al.
Publicado: (2022)